Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome

Journal:

Nature Communications

Published:

2025-12-19

DOI:

10.1038/s41467-025-67611-w

Affiliations:

10

Authors:

16

Go to article

Institutions	Authors	Share
Department of Biomedicine Basel, Switzerland	7.333333	0.46
University Hospital Zurich (UHZ), Switzerland	3.000000	0.19
University of Basel (UB), Switzerland	1.500000	0.09
Swiss Institute of Bioinformatics (SIB), Switzerland	1.000000	0.06
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	1.000000	0.06
The University of Tokyo (UTokyo), Japan	1.000000	0.06
University of Copenhagen (UCPH), Denmark	0.833333	0.05
Rigshospitalet, Denmark	0.333333	0.02

Interested in Oncology and Carcinogenesis?